Oxytocin

Oxytocin is a cyclic nonapeptide neuropeptide hormone synthesized in the paraventricular and supraoptic nuclei of the hypothalamus and released from the posterior pituitary. The peptide features a disulfide bond between cysteine residues at positions 1 and 6, creating a six-residue ring with a three-amino acid C-terminal tail. This structure is highly conserved across mammals and is shared with vasopressin (differing at only two positions), explaining significant cross-reactivity between the two hormone systems.

Oxytocin is FDA-approved as an intravenous agent for obstetric indications. The intranasal form (Syntocinon in some countries) is approved in Europe for labor induction but is under active investigation in the United States for psychiatric applications. A substantial body of research has positioned oxytocin at the intersection of social bonding, stress regulation, neuropsychiatry, and metabolic function.

Oxytocin acts through the oxytocin receptor (OXTR), a class A G protein-coupled receptor coupled to Gq/G11 signaling. OXTR is widely distributed in the brain (hypothalamus, limbic system, brainstem), uterus, mammary glands, cardiovascular system, gut, and adipose tissue, explaining oxytocin's pleiotropic effects.

In the uterus, OXTR activation stimulates myometrial contractions via phospholipase C activation, calcium release, and protein kinase C signaling — the pharmacological basis of its obstetric use. In the brain, oxytocin acts as a neuromodulator, attenuating amygdala activity (reducing fear and social anxiety), enhancing prosocial cognition and reciprocity, and modulating HPA axis activity to reduce cortisol responses to stress. In the peripheral immune system, oxytocin exerts anti-inflammatory effects, suppressing TNF-α, IL-6, and NF-κB activity, while acting as an antioxidant in cardiac and GI tissues. The peptide also influences metabolic function, suppressing appetite through hypothalamic signaling and improving insulin sensitivity.